3645 results for «2800»

Filter By

3645 results

The digital pulse: innovation in the cathlab

20 May 2026 – From EuroPCR 2026

This session highlights transformative innovations in the catheterization laboratory that prioritize patient-centered care and enhanced safety. Focus areas include advancements in radiation practice through new technology and the integration of artificial intelligence to improve image analysis, decision-making, and procedural efficiency in interventional cardiology.

Complex transfemoral TAVI: how to manage the root to success

20 May 2026 – From EuroPCR 2026

Addressing the challenges of complex transfemoral TAVI, this session provides expert guidance on managing difficult vascular access routes to ensure procedural success. Topics include advanced techniques for straightening pathways, managing hostile access, and innovative strategies for contrast-zero TAVI in challenging anatomies.

New strategies in STEMI treatments

20 May 2026 – From EuroPCR 2026

Investigate new strategies in STEMI treatment through data from international registries and clinical trials. This session examines the comparative efficacy of sirolimus versus paclitaxel-coated balloons, plaque modification in calcified lesions, novel cardioprotective techniques during primary PCI, and the role of AI-assisted ECG interpretation in STEMI pathways.

Complications during left main PCI: how to manage and how to avoid

20 May 2026 – From EuroPCR 2026

This session addresses the identification, prevention, and management of complications arising during left main percutaneous coronary intervention (PCI). Through detailed case presentations and analyses, it highlights anatomical and procedural risk factors, strategies to anticipate and recognize complications such as stent deformation and coronary perforation, and effective...

Complications during left main PCI: how to manage and how to avoid

Debate: how will AI change the cardiology landscape in the next five years?

20 May 2026 – From EuroPCR 2026

Delve into the anticipated impact of artificial intelligence on cardiology over the next five years. This session addresses AI's role in reporting, triage, workflow optimization, and decision-making, while distinguishing realistic clinical benefits from hype. It also discusses governance, accountability, and legal considerations surrounding AI adoption in...

Bleeding and thrombotic risk in LAA closure patients

20 May 2026 – From EuroPCR 2026

This session provides a thorough examination of bleeding and thrombotic risks in patients undergoing left atrial appendage (LAA) closure. It reviews risk factors for device-related thrombosis, compares anticoagulation strategies post-procedure, and presents real-world clinical outcomes, particularly in high bleeding risk populations and special groups such as...

Optimising bifurcation PCI: learning from randomised controlled trials

20 May 2026 – From EuroPCR 2026

This session delves into optimizing bifurcation PCI by examining contemporary European practices and outcomes from multiple randomized controlled trials. Key topics include multivessel TALENT trial results, 30-day outcomes of left main PCI with sirolimus-eluting stents from the NAGOMI COMPLEX study, comparative insights from the CROSS-LCX Registry...

Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access

20 May 2026 – From EuroPCR 2026

This session investigates the boundaries of transfemoral access for TAVI and strategies to safely extend its use. It also provides a comprehensive review of facilitated transfemoral TAVI techniques and explores alternative access options, offering critical insights for managing challenging TAVI cases.

Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access

TAVI: head-to-head trials

20 May 2026 – From EuroPCR 2026

This session presents head-to-head comparisons of TAVI devices from recent randomized trials and registries. Highlights include three-year outcomes from the SMART trial, two-year data from the LANDMARK trial on contemporary valves, comparisons of intra- and supra-annular self-expanding valves, evaluations in large annuli, the ALLEGRA trial focusing...

TAVI: head-to-head trials

Lost, crushed, fractured: stent complications in real life

20 May 2026 – From EuroPCR 2026

This session addresses real-world challenges of stent complications including loss, crushing, and fracture during PCI. Through case-based discussions, it explores complex scenarios such as stent dislodgement, embolisation, and management strategies when initial plans evolve into complicated realities.

Lost, crushed, fractured: stent complications in real life

All you need to know about interventional therapies for pulmonary embolism

20 May 2026 – From EuroPCR 2026

Focused on interventional therapies for pulmonary embolism, this session guides on establishing and sustaining Pulmonary Embolism Response Teams (PERT), refining patient selection for intervention, choosing appropriate technologies, and identifying intraprocedural markers indicating successful treatment outcomes.

All you need to know about interventional therapies for pulmonary embolism

Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection

20 May 2026 – From EuroPCR 2026

This session critically evaluates antithrombotic therapy following TAVI, addressing optimal agents and regimens tailored to patients with and without atrial fibrillation. It also reviews clinical presentations and management of valve thrombosis post-TAVI, using guideline-based approaches and real-world cases to individualize patient care.

Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection

Unusual complexities, uncommon complications and innovative solutions

20 May 2026 – From EuroPCR 2026

This session showcases innovative solutions to unusual complexities and rare complications in interventional cardiology. Through detailed case presentations, it examines ambiguous CTO management, giant coronary aneurysm complications post-PCI, and unforeseen issues arising from coronary atherectomy for calcified nodules.

Unusual complexities, uncommon complications and innovative solutions

Other valvular and structural interventions

20 May 2026 – From EuroPCR 2026

Covering a spectrum of valvular and structural heart interventions, this session discusses systemic aortic valve TEER in complex congenital cases, compares TAVI and surgical AVR outcomes via meta-analysis, highlights radiation protection advances in complex endovascular repair, and presents combined mitral and tricuspid TEER techniques, novel ultrasound...

Other valvular and structural interventions

Dangers of dissection: the role of ICI

20 May 2026 – From EuroPCR 2026

This session explores the critical role of intracoronary imaging (ICI) in diagnosing and managing coronary artery dissections. Cases include fenestration techniques, stent migration challenges, polytrauma patient management, route selection dilemmas, and intricate procedural navigation to achieve successful outcomes.

Dangers of dissection: the role of ICI

When transcatheter LAA closure becomes challenging

20 May 2026 – From EuroPCR 2026

This session addresses the technical and clinical challenges encountered during transcatheter left atrial appendage (LAA) closure, including management of peri-device leaks, alternative access routes like transhepatic approaches, complications following surgical closures, and rare procedural adversities such as accidental aortic puncture.

When transcatheter LAA closure becomes challenging

Interventions for heart failure: shock and beyond

20 May 2026 – From EuroPCR 2026

Focused on interventions for heart failure, this session presents data on mitral regurgitation post-alcohol septal ablation, outcomes from high-risk PCI supported by Impella CP, evolving trends in ECMO utilization for cardiogenic shock, and six-month patient outcomes guided by shock team management strategies.

Prevention and management of PCI complications

20 May 2026 – From EuroPCR 2026

This session addresses the prevention and management strategies for complications arising during percutaneous coronary intervention (PCI). It presents real-world cases including management of entrapped guidewires, thrombosed aneurysms, catheter kinking, stent retrieval challenges, and complex retrieval scenarios, offering valuable insights into effective complication resolution techniques.

Best cases in stable CAD

20 May 2026 – From EuroPCR 2026

This session showcases exemplary cases in stable coronary artery disease, emphasizing complex diagnostic and therapeutic challenges such as ambiguous angiographic findings, refractory vasospastic angina, catastrophic no-reflow phenomena, and the application of physiology-guided PCI and coronary sinus reducers.

Complications in CAD PCI

20 May 2026 – From EuroPCR 2026

This session focuses on the recognition and management of complications during coronary artery disease PCI. It includes cases of acute guide catheter crises, rare post-PCI chest pain etiologies, innovative stent retrieval techniques, and critical procedural challenges, providing an educational journey through complex complication management.

Didn’t find what you were looking for?